$CBRS

Feldman Andrew D. sold $3.1M of CBRS

Feldman Andrew D. (CEO, President) sold 17,990 shares of Cerebras Systems Inc. (CBRS) at an average of $173.06 ($169.07–$184.73, $3.11M total) across 12 trades on 2026-06-25.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Jun 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The disclosure provides a concrete insider selling event (size, dates, price range, and post-transaction holdings), which may influence short-term sentiment but does not change the company’s fundamentals on its own.

02

Market read

Traders may monitor for follow-on insider activity or any concurrent company news, but this filing alone is unlikely to drive a durable repricing.

03

What to watch

The article does not state motivations, tax planning, or whether other insiders or the company have concurrent catalysts; traders should avoid over-weighting insider-sale narratives without corroborating news.

Relevance 6/10Novelty 4/10Timing: filed 2026-06-29 after trades on 2026-06-25

Background

The article is a SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems CEO Andrew Feldman sold about $3.11M of CBRS shares in an open-market Form 4, leaving 0 shares after the trades.

Expected impact

Near-term sentiment impact is likely limited, with any price reaction more dependent on broader tape and company-specific catalysts than this filing alone.

Evidence & confidence

The filing discloses transaction size, pricing range, and that holdings fell to zero, but it does not provide new operational, financial, or regulatory information.

Market effects

Minimal, as this is a single-company insider transaction without sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity or diversification, and the absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • Cerebras Systems Inc.

    Subject of the Form 4 insider sale by its CEO/President.

  • Andrew D. Feldman

    CEO and President who sold shares and reported 0 shares after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.